Moderna (MRNA) Change in Cash (2018 - 2026)
Moderna (MRNA) reported Change in Cash of -$688.0 million for Q1 2026, down 127.06% year-over-year from $2.5 billion in Q1 2025, and down 147.03% quarter-over-quarter from $1.5 billion in Q4 2025.
Moderna (MRNA) Change in Cash (2018 - 2026) Analysis & Trends
Moderna (MRNA) has 9 years of Change in Cash data on file, last reported at -$688.0 million in Q1 2026.
- Change in Cash for Q1 2026 came in at -$688.0 million, down 127.06% year-over-year; the trailing twelve-month figure through Mar 2026 was $283.0 million (up 163.6% YoY), and the FY2025 annual result was $668.0 million, up 166.87% from the prior year.
- Change in Cash fell to -$688.0 million in Q1 2026 per MRNA's latest filing, from $1.5 billion in the prior quarter.
- Over five years, Change in Cash peaked at $1.5 billion in Q4 2025 and troughed at -$2.2 billion in Q2 2022.
- A 5-year average of -$291.2 million and a median of -$147.0 million in 2025 frame the typical range for Change in Cash.
- The sharpest annual moves came in 2022 and 2024: Change in Cash slumped 1450.93% in 2022, then surged 1228.0% in 2024.
- A 5-year view of Change in Cash shows it stood at $176.0 million in 2022, then sank by 114.2% to -$25.0 million in 2023, then surged by 1228.0% to $282.0 million in 2024, then jumped by 418.79% to $1.5 billion in 2025, then tumbled by 147.03% to -$688.0 million in 2026.
- Business Quant data shows MRNA's Change in Cash at -$688.0 million in Q1 2026, $1.5 billion in Q4 2025, and -$147.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 2.44 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 623.00 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -2.44 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 417.10 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -45.97 Mn |
| 10 | Moderna | 25.27 Bn | 20.06 Bn | -566.00 Mn | -688.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -688.00 Mn |
| Dec 31, 2025 | 1.46 Bn |
| Sep 30, 2025 | -147.00 Mn |
| Jun 30, 2025 | -345.00 Mn |
| Mar 31, 2025 | -303.00 Mn |
| Dec 31, 2024 | 282.00 Mn |
| Sep 30, 2024 | -833.00 Mn |
| Jun 30, 2024 | 409.00 Mn |
| Mar 31, 2024 | -857.00 Mn |
| Dec 31, 2023 | -25.00 Mn |
| Sep 30, 2023 | -869.00 Mn |
| Jun 30, 2023 | 361.00 Mn |
| Mar 31, 2023 | 244.00 Mn |
| Dec 31, 2022 | 176.00 Mn |
| Sep 30, 2022 | 156.00 Mn |
| Jun 30, 2022 | -2.18 Bn |
| Mar 31, 2022 | -1.80 Bn |
| Dec 31, 2021 | 1.30 Bn |
| Sep 30, 2021 | -53.00 Mn |
| Jun 30, 2021 | 161.00 Mn |